← Back to Search

Licorice for Drug-Food Interaction

Phase 1
Waitlist Available
Research Sponsored by University of Illinois at Chicago
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 14 days
Awards & highlights

Study Summary

This study is evaluating whether a red clover dietary supplement is safe to use with FDA-approved drugs.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 14 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 14 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
1. Area Under the Curve (AUC)
Secondary outcome measures
1. Apparent Clearance
2. Peak Concentration
3. Time for Peak Concentration
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: G.GlabraExperimental Treatment5 Interventions
single arm
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Dextromethorphan
FDA approved
Caffeine
FDA approved
Licorice
2008
Completed Phase 4
~340
Tolbutamide
FDA approved
Alprazolam
FDA approved

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

University of Illinois at ChicagoLead Sponsor
607 Previous Clinical Trials
1,559,337 Total Patients Enrolled
Oregon State UniversityOTHER
49 Previous Clinical Trials
8,362 Total Patients Enrolled
Richard vanBreemen, PhDStudy DirectorUniversity of Illinois at Chicago
1 Previous Clinical Trials
20 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~3 spots leftby Apr 2025